Russia still expects to ink deal with Astra Zeneca for Covid-19 vaccine
Russia still expects to conclude a deal with AstraZeneca to manufacture the Covid-19 vaccine that it is working on with Oxford University.
AstraZeneca
9,990.00p
15:45 15/11/24
-2.93%
-302.00p
FTSE 100
8,060.61
15:45 15/11/24
n/a
n/a
FTSE 350
4,453.56
15:45 15/11/24
n/a
n/a
FTSE All-Share
4,411.85
15:45 15/11/24
n/a
n/a
GSK
1,299.00p
15:45 15/11/24
-4.03%
-54.50p
Pharmaceuticals & Biotechnology
19,259.77
15:45 15/11/24
-2.70%
-535.19
In an interview with Reuters, Kirill Dmitriev, the head of the Russian Direct Investment Fund, said he still expected such a deal to go through, despite allegations that Moscow had tried to steal research data by hacking into the computer networks of scientific institutes around the world.
British intelligence ascribed a 95% probability to the chance of the hackers being linked to the Russian state.
Indeed, such a deal might be announced later on Friday, he said.
"There's nothing that needs to be stolen [...] It's all going to be given to Russia."